Drug drug interaction or drug food interaction list of questions and answer

Reading File

Asking for Preferences

Finding Sources

Here is a comprehensive Q&A list covering Drug-Drug Interactions (DDI) and Drug-Food Interactions (DFI) at PharmD level, sourced from Goodman & Gilman's, Katzung's, Lippincott, Miller's Anesthesia, and other authoritative textbooks.

Drug-Drug Interactions (DDI) and Drug-Food Interactions (DFI)

Q&A List - PharmD Level

PART A: DRUG-DRUG INTERACTIONS (DDI)

Section 1: Pharmacokinetic DDIs - Metabolism (CYP450)

Q1. What is a drug-drug interaction? A: A DDI is an in vivo phenomenon where co-administration of one drug alters the effects or pharmacokinetics of another drug. In vitro physical or chemical incompatibilities are NOT classified as drug interactions. - Miller's Anesthesia, 10e

Q2. What are the two main mechanisms of drug-drug interactions? A:

Pharmacokinetic interactions: One drug alters the ADME (absorption, distribution, metabolism, or excretion) of another.
Pharmacodynamic interactions: Drugs interact at the receptor or physiological level, causing additive, synergistic, or antagonistic effects, without changing each other's plasma concentrations.

Q3. Which CYP450 enzyme is most commonly involved in clinically significant drug interactions? A: CYP3A4 - it metabolizes approximately 50% of marketed drugs. Key inhibitors include ketoconazole, erythromycin, diltiazem, and grapefruit juice. Key inducers include rifampin, carbamazepine, phenytoin, and St. John's wort.

Q4. A patient on warfarin starts rifampin. What happens and why? A: Rifampin is a potent CYP2C9 and P-glycoprotein inducer. It increases warfarin metabolism, dramatically reducing warfarin plasma levels and anticoagulant effect. The INR will fall, increasing thrombosis risk. Warfarin dose must be increased and INR closely monitored. When rifampin is stopped, the enzyme induction reverses and warfarin toxicity (bleeding) can result if the dose is not reduced.

Q5. A patient taking simvastatin is started on clarithromycin. What is the concern? A: Clarithromycin is a potent CYP3A4 inhibitor. Simvastatin is extensively metabolized by CYP3A4. Inhibition leads to elevated simvastatin plasma levels, increasing the risk of myopathy and potentially fatal rhabdomyolysis. Simvastatin should be temporarily held or switched to a non-CYP3A4 dependent statin (pravastatin, rosuvastatin). - Goodman & Gilman's

Q6. Why is the combination of statins with fibrates or niacin potentially dangerous? A: When statins are co-administered with fibrates or niacin, there is likely enhanced pharmacodynamic inhibition of skeletal muscle cholesterol synthesis, increasing myopathy risk. This pharmacodynamic interaction (not purely pharmacokinetic) led the FDA in 2016 to withdraw approval of statin/fibrate and statin/niacin combination products. - Goodman & Gilman's

Q7. What drugs are substrates of OATP1B1 transporter, and why is this clinically important? A: Statins (e.g., rosuvastatin, pravastatin, atorvastatin) are substrates of the hepatic uptake transporter OATP1B1 (SLCO1B1). Drugs that inhibit OATP1B1 - such as ciclosporin - can markedly raise statin plasma levels, increasing myopathy risk even without CYP450 involvement. Tacrolimus does NOT significantly inhibit OATP1B1, so it lacks this statin DDI. - Comprehensive Clinical Nephrology; Goodman & Gilman's

Q8. Clopidogrel is a prodrug requiring activation. Which DDI compromises its antiplatelet effect? A: Clopidogrel is converted to its active metabolite by CYP2C19. Proton pump inhibitors (especially omeprazole) inhibit CYP2C19, reducing clopidogrel activation and thereby decreasing its antiplatelet efficacy. This can increase the risk of major adverse cardiovascular events in patients post-stent. Pantoprazole has less CYP2C19 inhibition and may be preferred. - Lippincott Pharmacology

Q9. What is the most serious DDI associated with MAO inhibitors? A: MAOIs carry two life-threatening DDIs:

Serotonin syndrome - caused by combining MAOIs with serotonin-enhancing drugs (SSRIs, SNRIs, meperidine, tramadol, triptans, St. John's wort). The most classic combination is meperidine + MAOI. Serotonin syndrome presents with the triad: mental status changes, autonomic hyperactivity, and neuromuscular abnormalities (clonus).
Hypertensive crisis - from tyramine-containing foods (see DFI section) or sympathomimetics.

Goodman & Gilman's; Katzung's; Miller's Anesthesia

Q10. Why is the combination of fluoxetine + MAOI absolutely contraindicated? A: Fluoxetine inhibits serotonin reuptake (SSRI), and MAOIs inhibit serotonin degradation. Together, they cause massive serotonin accumulation in the CNS, resulting in potentially fatal serotonin syndrome. Additionally, fluoxetine has a very long half-life (~4-6 days for the parent drug; ~4-16 days for active metabolite norfluoxetine), requiring a 5-week washout before starting an MAOI. - Katzung's

Q11. How does the NSAIDs + aspirin interaction undermine cardiovascular protection? A: Non-selective NSAIDs (e.g., ibuprofen, naproxen) competitively bind the COX-1 active site, blocking aspirin's irreversible acetylation of platelet COX-1. This pharmacokinetic access competition undermines the cardioprotective antiplatelet effect of low-dose aspirin. Celecoxib (selective COX-2 inhibitor) is unlikely to cause this specific interaction but carries its own direct cardiovascular risk. - Goodman & Gilman's

Q12. What is a pharmacodynamic drug interaction? Give a clinical example. A: A pharmacodynamic interaction occurs when two drugs affect the same physiological system, receptor, or endpoint - without necessarily changing each other's concentrations:

Additive/synergistic: Morphine + benzodiazepine = additive CNS and respiratory depression.
Antagonistic: Naloxone reverses opioid-induced respiratory depression.
Synergistic toxicity: ACE inhibitors + potassium-sparing diuretics = additive hyperkalemia.

Q13. Why are neuromuscular blocking agents (NMBAs) particularly susceptible to DDIs? A: NMBAs are affected by many co-administered drugs:

Enhanced block (prolonged paralysis): Aminoglycosides, tetracyclines, volatile anesthetics, calcium channel blockers, magnesium, and hypothermia all potentiate NMBAs.
Reduced block (resistance): Chronic phenytoin or carbamazepine use leads to resistance to non-depolarizing NMBAs through upregulation of acetylcholine receptors and enzyme induction.
Miller's Anesthesia

Q14. What is the significance of protein-binding displacement DDIs? A: Drugs with high protein binding (>95%) can be displaced from albumin by co-administered drugs, transiently increasing free (active) drug concentration. However, the clinical significance is often overstated - the displaced drug is also more available for distribution and elimination, so the free fraction increase is usually transient. Most clinically significant interactions attributed to displacement also involve metabolism inhibition.

Q15. What DDIs are associated with immunosuppressant drug cyclosporine? A:

CYP3A4 inhibitors (ketoconazole, diltiazem, erythromycin) increase cyclosporine levels - risk of nephrotoxicity.
CYP3A4 inducers (rifampin, phenytoin) decrease cyclosporine levels - risk of transplant rejection.
Co-administration with statins (via OATP1B1 inhibition) increases statin levels - myopathy risk.
Nephrotoxic drugs (aminoglycosides, amphotericin B, NSAIDs) - additive nephrotoxicity.
Lippincott Pharmacology; Comprehensive Clinical Nephrology

Q16. What is the mechanism of the linezolid-SSRI interaction? A: Linezolid is a reversible, non-selective MAOI (this is unrelated to its antibacterial action against bacterial ribosomes). When combined with SSRIs, SNRIs, or other serotonergic drugs, it can cause serotonin syndrome. This interaction is often overlooked because linezolid is not classified primarily as an antidepressant. - Tintinalli's Emergency Medicine

Q17. A patient takes metformin and is given IV iodinated contrast. What is the concern? A: IV contrast can cause acute kidney injury. Metformin is renally cleared - if AKI occurs and metformin accumulates, there is risk of lactic acidosis. Current guidelines recommend holding metformin 48 hours before and after IV contrast in patients with eGFR <60 mL/min or when AKI risk is elevated.

Q18. What is the interaction between dronedarone and dabigatran? A: Dronedarone inhibits P-glycoprotein (P-gp), which is the primary efflux transporter for dabigatran. P-gp inhibition increases dabigatran plasma levels, raising bleeding risk. Dose adjustment of dabigatran is necessary when used with dronedarone. - Braunwald's Heart Disease

Section 2: Pharmacokinetic DDIs - Absorption

Q19. How do antacids interact with fluoroquinolones and tetracyclines? A: Antacids containing aluminum, magnesium, or calcium form insoluble chelation complexes with fluoroquinolones (ciprofloxacin, levofloxacin) and tetracyclines (doxycycline, tetracycline). This chelation dramatically reduces GI absorption (bioavailability). Administration should be separated by at least 2 hours before or 4-6 hours after the antibiotic.

Q20. How does food affect levodopa absorption in Parkinson's therapy? A: High-protein meals compete with levodopa for transport across the intestinal epithelium and blood-brain barrier via the large neutral amino acid (LNAA) transporter. This reduces levodopa CNS delivery and clinical effect. Patients are advised to take levodopa 30-60 minutes before meals or on a low-protein diet.

PART B: DRUG-FOOD INTERACTIONS (DFI)

Section 3: Warfarin and Vitamin K-Containing Foods

Q21. What is the most clinically important drug-food interaction involving warfarin? A: Warfarin's anticoagulant effect is antagonized by dietary vitamin K. Foods rich in vitamin K - particularly green leafy vegetables (spinach, kale, broccoli, Brussels sprouts, collard greens) - can reduce INR and increase thrombosis risk. Patients should maintain a consistent (not necessarily zero) vitamin K intake. Sudden large increases cause subtherapeutic anticoagulation; sudden decreases cause supratherapeutic anticoagulation. - Tintinalli's Emergency Medicine

Q22. List other substances that interact with warfarin. A:

Increase warfarin effect (raise INR/bleeding risk): Amiodarone, metronidazole, fluconazole, cranberry juice, fish oil, alcohol (acute), mango, vitamin E.
Decrease warfarin effect (lower INR/clot risk): Rifampin, carbamazepine, St. John's wort, griseofulvin, high vitamin K foods, alcohol (chronic - enzyme induction).
Tintinalli's Emergency Medicine; Goodman & Gilman's

Section 4: MAOI and Tyramine (Cheese Reaction)

Q23. Explain the MAOI-tyramine (cheese) reaction. A: MAO-A in the gut wall normally metabolizes dietary tyramine before it enters systemic circulation. When MAO is inhibited by an MAOI, tyramine is absorbed intact in large quantities. Tyramine then enters adrenergic nerve terminals via norepinephrine transporters (NET), displacing stored norepinephrine and causing a massive sympathomimetic surge. This results in:

Severe hypertensive crisis (can exceed 200/120 mmHg)
Severe headache (classically occipital), diaphoresis, flushing
Risk of hypertensive encephalopathy, stroke, MI, death This interaction can occur up to 3 weeks after stopping a non-selective MAOI. - Katzung's; ROSEN's Emergency Medicine

Q24. List tyramine-rich foods that must be avoided with MAOIs. A: Aged cheeses (cheddar, brie, camembert, blue cheese), fermented/cured meats (pepperoni, salami, sausage), pickled/fermented foods (sauerkraut, kimchi), soy sauce, miso, broad bean pods (fava beans), tap beer, draft beer, red wine, aged wines, concentrated yeast extracts (Marmite, Vegemite), overripe fruit, smoked fish.

Q25. What is the clinical management of MAOI-tyramine hypertensive crisis? A:

IV phentolamine (alpha-blocker) or labetalol.
Sublingual nifedipine was used historically but is no longer recommended.
Asymptomatic patients who ingested tyramine-containing food while on MAOI can be observed for 6 hours and discharged if no symptoms develop.
ROSEN's Emergency Medicine

Section 5: Grapefruit Juice Interactions

Q26. What is the mechanism of the grapefruit juice-drug interaction? A: Grapefruit juice contains furanocoumarins (primarily bergamottin and 6',7'-dihydroxybergamottin) that irreversibly inhibit intestinal CYP3A4. This is a mechanism-based (irreversible) inhibition, meaning:

A single glass of grapefruit juice can inhibit CYP3A4 for up to 24-72 hours.
Bioavailability of CYP3A4-metabolized drugs increases, raising plasma levels and risk of toxicity.
Goldman-Cecil Medicine; Dermatology (Elsevier); Brenner and Rector's Kidney

Q27. Which drugs have clinically significant interactions with grapefruit juice? A:

Drug Class	Drugs Affected	Risk
Calcium channel blockers	Felodipine, amlodipine, nifedipine, verapamil	Hypotension
Statins	Simvastatin, lovastatin, atorvastatin	Myopathy/rhabdomyolysis
Calcineurin inhibitors	Cyclosporine, tacrolimus	Nephrotoxicity/toxicity
HIV PIs	Saquinavir, indinavir	Toxicity
Immunosuppressants	Sirolimus	Toxicity
Anxiolytics	Midazolam, triazolam	Excessive sedation
Antihistamines	Fexofenadine*	Reduced levels

*Fexofenadine is an exception - grapefruit juice inhibits OATP1A2 transporter, reducing fexofenadine absorption (lower levels). - Lippincott Pharmacology

Q28. How does grapefruit juice affect fexofenadine differently from most drugs? A: Most grapefruit juice interactions involve CYP3A4 inhibition, increasing drug bioavailability. Fexofenadine is NOT metabolized by CYP3A4 - instead, it relies on OATP1A2 for intestinal uptake. Grapefruit juice inhibits this uptake transporter, which reduces fexofenadine absorption. This results in lower (not higher) plasma concentrations and decreased antihistamine effect. Orange juice has a similar effect. - Lippincott Pharmacology

Q29. Can orange juice substitute for grapefruit juice in patients on sensitive medications? A: Orange juice does NOT significantly inhibit CYP3A4 (it lacks furanocoumarins), so it is a safe alternative for patients taking CYP3A4-metabolized drugs. However, orange juice also inhibits OATP transporters, so it shares the fexofenadine-type interaction. The clinical guidance is: use orange juice as a substitute for CYP3A4 concerns, but monitor for transporter-mediated interactions. - Dermatology (Elsevier)

Section 6: Dairy and Mineral Interactions

Q30. Why should doxycycline not be taken with milk? A: Calcium in milk (and dairy products) chelates with tetracyclines (including doxycycline) in the GI tract, forming poorly soluble calcium-tetracycline complexes. This significantly reduces GI absorption and bioavailability. Doxycycline should be taken on an empty stomach or at least 1-2 hours before or 2 hours after dairy products. (Note: doxycycline has slightly less interaction than other tetracyclines but still clinically significant.)

Q31. What is the iron-quinolone/tetracycline interaction? A: Iron (Fe2+/Fe3+) chelates with both fluoroquinolones and tetracyclines, forming insoluble complexes in the gut. This reduces antibiotic bioavailability by up to 50-90%. Iron supplements, iron-rich foods, or multivitamins containing iron must be separated from these antibiotics by at least 2 hours before or 4-6 hours after. This applies to zinc, magnesium, and aluminum as well.

Section 7: Alcohol and Drug Interactions

Q32. List the major drug-alcohol interactions and their mechanisms. A:

Drug	Interaction with Alcohol	Mechanism	Outcome
Metronidazole, tinidazole	Disulfiram-like reaction	Inhibit aldehyde dehydrogenase - acetaldehyde accumulation	Flushing, nausea, tachycardia
Disulfiram	Severe disulfiram reaction	Same as above (intentional)	Severe nausea, vomiting, hypotension
CNS depressants (benzodiazepines, opioids, antihistamines)	Additive CNS/respiratory depression	Pharmacodynamic synergism	Sedation, respiratory failure
Metformin	Increased lactic acidosis risk	Alcohol inhibits gluconeogenesis + metformin effect	Hypoglycemia, lactic acidosis
Warfarin (acute)	Increased anticoagulation	Competitive CYP2C9 inhibition	Bleeding
Warfarin (chronic)	Decreased anticoagulation	CYP2C9 induction	Thrombosis
Acetaminophen	Hepatotoxicity	CYP2E1 induction increases toxic NAPQI metabolite	Liver failure

Q33. What is the disulfiram reaction, and which antibiotic can trigger it? A: The disulfiram reaction occurs when aldehyde dehydrogenase (ALDH) is inhibited. Acetaldehyde (the first metabolite of alcohol) accumulates, causing: flushing, severe nausea and vomiting, headache, palpitations, hypotension, and dyspnea. Metronidazole (and to a lesser extent tinidazole and cefoperazone, cefamandole) can trigger this reaction. Patients must be counseled to avoid all alcohol-containing products (including mouthwash, food cooked with wine, cough syrups) during and for 48 hours after completing metronidazole.

Section 8: Herbal Supplements and Drug Interactions

Q34. How does St. John's Wort interact with medications? A: St. John's Wort (Hypericum perforatum) is a potent inducer of CYP3A4, CYP2C9, and P-glycoprotein. It significantly reduces plasma levels of:

Cyclosporine (transplant rejection reported)
HIV antiretrovirals (protease inhibitors, NNRTIs) - loss of viral suppression
Oral contraceptives - contraceptive failure
Warfarin - subtherapeutic anticoagulation
Digoxin (P-gp substrate) - decreased levels Additionally, St. John's Wort has mild MAO inhibitory activity and can contribute to serotonin syndrome when combined with SSRIs. - Tintinalli's Emergency Medicine; Katzung's

Q35. What is the interaction between Chinese herbal medicines and warfarin? A: Many traditional Chinese herbal preparations affect warfarin metabolism or possess anticoagulant/antiplatelet activity of their own:

Danshen (Salvia miltiorrhiza): inhibits CYP2C9, increases warfarin effect.
Dong quai: contains coumarins - additive anticoagulant effect.
Ginkgo biloba: antiplatelet effect - additive bleeding risk.
Garlic: antiplatelet effect.
Ginger: inhibits thromboxane synthesis. These interactions are unpredictable and often underreported because patients do not consider herbal products as "medicines." - ROSEN's Emergency Medicine

Section 9: Food Effects on Drug Absorption

Q36. What are the types of food effects on drug absorption? A:

Food increases absorption: Itraconazole (acidic food increases dissolution), griseofulvin (fatty meal increases absorption), lovastatin, atazanavir - must be taken WITH food.
Food decreases absorption: Fluoroquinolones with dairy/antacids, tetracyclines with dairy, levothyroxine (take 30-60 min before breakfast on empty stomach), alendronate (must be taken with plain water on empty stomach).
Food has no significant effect: Most medications.

Q37. Why must alendronate (bisphosphonate) be taken on an empty stomach with plain water? A: Alendronate has very poor oral bioavailability (~0.6%). Any food, beverage (other than plain water), or medication taken within 30 minutes reduces absorption by more than 60%. Coffee, orange juice, and calcium-containing foods are all problematic. Additionally, alendronate is directly esophagotoxic - patients must remain upright for at least 30 minutes after taking it to prevent esophageal ulceration.

Q38. What is the interaction between high-fat food and some antiretrovirals? A: Some HIV antiretrovirals have food-dependent absorption:

Require high-fat meal: Atazanavir, lopinavir/ritonavir, rilpivirine - food increases bioavailability significantly.
Avoid with fatty food: Didanosine - food decreases absorption.
Dronedarone: Absorption doubles when taken with food - dose 400 mg twice daily WITH food (the standard recommendation). - Braunwald's Heart Disease

Section 10: High-Yield Clinical Scenarios

Q39. A patient on phenelzine (MAOI) eats aged blue cheese. Two hours later they present with severe occipital headache and BP 210/120. What happened and how is it managed? A: This is a classic MAOI-tyramine hypertensive crisis (cheese reaction). Phenelzine inhibits gut MAO-A, allowing dietary tyramine to be absorbed intact. Tyramine causes norepinephrine release from sympathetic terminals, leading to severe hypertension. Management:

IV phentolamine (alpha-adrenergic blockade) or labetalol.
Monitor in ED; observe for at least 6 hours.
Counsel patient on all tyramine-containing foods to avoid for the duration of MAOI therapy and 2-3 weeks after stopping.

Q40. A patient stabilized on cyclosporine after renal transplant starts taking St. John's Wort for depression. Three weeks later, the trough cyclosporine level has dropped significantly. Explain. A: St. John's Wort is a potent CYP3A4 and P-gp inducer. Cyclosporine is both a CYP3A4 substrate and a P-gp substrate. Induction leads to increased first-pass and hepatic metabolism + increased P-gp-mediated intestinal efflux of cyclosporine, dramatically lowering plasma trough levels. This places the patient at high risk of acute rejection. St. John's Wort is absolutely contraindicated in transplant patients.

Q41. Why is it dangerous to take simvastatin with a large daily serving of grapefruit juice? A: Grapefruit juice irreversibly inhibits intestinal CYP3A4. Simvastatin undergoes high first-pass CYP3A4 metabolism in the intestinal wall. Inhibition of this enzyme markedly increases simvastatin bioavailability and plasma levels. High statin levels inhibit HMG-CoA reductase in skeletal muscle, disrupting cholesterol synthesis and causing myopathy or rhabdomyolysis (myalgia, elevated CK, myoglobinuria, acute kidney injury).

Q42. What counseling points should a pharmacist provide to a patient starting an MAOI? A:

Tyramine restriction: Avoid all aged cheeses, cured meats, fermented foods, draft beer, red wine, yeast extracts, overripe fruit, and fava bean pods.
Drug interaction avoidance: No SSRIs, SNRIs, meperidine, tramadol, triptans, linezolid, dextromethorphan (in OTC cough syrups), sympathomimetics (in decongestants like pseudoephedrine).
Washout periods: Allow 14 days washout after stopping MAOI before starting serotonergic drugs; 5 weeks if stopping fluoxetine before an MAOI.
Duration: Tyramine restriction and drug restrictions persist 2-3 weeks after stopping a non-selective MAOI.
Emergency identification: Carry a medical alert card.

Q43. Compare pharmacokinetic vs. pharmacodynamic DDIs with one clinical example each. A:

Feature	Pharmacokinetic DDI	Pharmacodynamic DDI
Mechanism	Alters ADME of co-drug	Alters effect without changing concentration
Plasma levels	Changed	Unchanged
Example	Ketoconazole + midazolam: CYP3A4 inhibition increases midazolam levels, causing excessive sedation	Morphine + diazepam: additive CNS depression without altering plasma concentrations of either drug
Predictability	Predictable based on CYP/transporter profile	Based on receptor/physiological overlap

Q44. What are the key P-glycoprotein (P-gp) DDIs relevant to clinical practice? A:

P-gp substrates (affected drugs): Digoxin, dabigatran, fexofenadine, loperamide, many HIV PIs, vincristine.
P-gp inhibitors (raise substrate levels): Cyclosporine, dronedarone, verapamil, quinidine, erythromycin, ritonavir.
P-gp inducers (lower substrate levels): Rifampin, St. John's Wort, carbamazepine.
Classic example: Quinidine + digoxin - quinidine inhibits P-gp-mediated renal digoxin secretion, increasing digoxin levels and risk of digoxin toxicity.

Q45. Summarize the highest-priority DDIs and DFIs every pharmacist must know. A:

Interaction	Mechanism	Consequence	Action
MAOI + SSRIs/meperidine	Serotonin excess	Fatal serotonin syndrome	Contraindicated
MAOI + tyramine foods	Sympathomimetic surge	Hypertensive crisis	Dietary restriction
Warfarin + rifampin	CYP2C9 induction	Loss of anticoagulation	Avoid; monitor INR
Warfarin + vitamin K foods	Pharmacodynamic antagonism	Reduced INR	Consistent diet
Simvastatin + CYP3A4 inhibitors	CYP3A4 inhibition	Rhabdomyolysis	Switch statin
Grapefruit + CYP3A4 substrates	CYP3A4 inhibition	Drug toxicity	Avoid grapefruit
Metronidazole + alcohol	ALDH inhibition	Disulfiram reaction	Avoid alcohol
Clopidogrel + omeprazole	CYP2C19 inhibition	Loss of antiplatelet effect	Use pantoprazole
Quinidine + digoxin	P-gp inhibition	Digoxin toxicity	Reduce digoxin dose
Tetracycline/quinolones + Ca2+/Fe2+	Chelation	Reduced absorption	Separate by 2-4 hrs
St. John's Wort + cyclosporine	CYP3A4/P-gp induction	Transplant rejection	Contraindicated
Fluoroquinolones + antacids	Chelation	Reduced bioavailability	Separate by 2 hrs

Sources:

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Katzung's Basic and Clinical Pharmacology, 16th Ed.
Lippincott Illustrated Reviews: Pharmacology
Miller's Anesthesia, 10e
Tintinalli's Emergency Medicine
ROSEN's Emergency Medicine
Braunwald's Heart Disease
Brenner and Rector's The Kidney
Goldman-Cecil Medicine
Comprehensive Clinical Nephrology, 7th Ed.

This is a shared conversation. Sign in to Orris to start your own chat.